D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 43 Citations 7,831 95 World Ranking 3749 National Ranking 173

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Internal medicine
  • Antibody

Alain Venet mainly focuses on Immunology, Virology, Cytotoxic T cell, CD8 and T cell. The various areas that Alain Venet examines in his Immunology study include Peripheral blood mononuclear cell and Acquired immunodeficiency syndrome. His study in Virology is interdisciplinary in nature, drawing from both Immune system and Antigen.

The study incorporates disciplines such as Epitope and Jurkat cells in addition to Cytotoxic T cell. He combines subjects such as Ex vivo and Pathogenesis with his study of CD8. His research in T cell intersects with topics in Interleukin 2, Viremia, Antibody and Human leukocyte antigen.

His most cited work include:

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. (696 citations)
  • HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. (492 citations)
  • HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. (309 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Virology, Cytotoxic T cell, Viral load and CD8. Alain Venet usually deals with Immunology and limits it to topics linked to Acquired immunodeficiency syndrome and Pediatrics. His Virology study combines topics from a wide range of disciplines, such as Epitope, Antibody and CTL*.

Much of his study explores Cytotoxic T cell relationship to Antigen. His studies in Viral load integrate themes in fields like Viremia, Internal medicine, Pharmacotherapy, Cohort and Effector. His studies deal with areas such as Ex vivo, Human leukocyte antigen and Flow cytometry as well as CD8.

He most often published in these fields:

  • Immunology (80.61%)
  • Virology (60.20%)
  • Cytotoxic T cell (35.71%)

What were the highlights of his more recent work (between 2012-2016)?

  • Immunology (80.61%)
  • CD8 (36.73%)
  • Cytotoxic T cell (35.71%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Immunology, CD8, Cytotoxic T cell, Virology and Viral load. Viral replication, Viremia, Human leukocyte antigen, CD14 and Tumor necrosis factor alpha are the core of his Immunology study. His Human leukocyte antigen research incorporates elements of CTL* and Infection control.

His Cytotoxic T cell research incorporates themes from T cell and Antigen. His T cell research includes themes of Basal and Pharmacotherapy. His Viral load research includes elements of Interquartile range, Hazard ratio, Confidence interval, Natural history and Proportional hazards model.

Between 2012 and 2016, his most popular works were:

  • Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. (696 citations)
  • A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8(+) T Cells. (117 citations)
  • Elevated IP10 levels are associated with immune activation and low CD4⁺ T-cell counts in HIV controller patients. (69 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Internal medicine
  • Antibody

His primary scientific interests are in Immunology, Cytotoxic T cell, Viremia, Human leukocyte antigen and CD8. As part of his studies on Immunology, Alain Venet often connects relevant areas like Cell activation. His Viremia research is multidisciplinary, relying on both Titer, Antibody-dependent cell-mediated cytotoxicity, Viral replication, Interleukin and Interleukin 10.

His Human leukocyte antigen study integrates concerns from other disciplines, such as T cell and Antibody. His research on CD8 frequently connects to adjacent areas such as Viral load. His Antigen study frequently draws parallels with other fields, such as Virology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.

Asier Sáez-Cirión;Charline Bacchus;Laurent Hocqueloux;Véronique Avettand-Fenoel.
PLOS Pathogens (2013)

1027 Citations

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Asier Sáez-Cirión;Christine Lacabaratz;Olivier Lambotte;Pierre Versmisse.
Proceedings of the National Academy of Sciences of the United States of America (2007)

684 Citations

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Olivier Lambotte;Faroudy Boufassa;Yoann Madec;Ahn Nguyen.
Clinical Infectious Diseases (2005)

437 Citations

Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.

J Estaquier;T Idziorek;F de Bels;F Barré-Sinoussi.
Proceedings of the National Academy of Sciences of the United States of America (1994)

330 Citations

CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients

Cécile Goujard;Mojgan Bonarek;Laurence Meyer;Fabrice Bonnet.
Clinical Infectious Diseases (2006)

245 Citations

CD8+ T Cells Specific for EBV, Cytomegalovirus, and Influenza Virus Are Activated during Primary HIV Infection

Jean-Marc Doisne;Alejandra Urrutia;Christine Lacabaratz-Porret;Cécile Goujard.
Journal of Immunology (2004)

245 Citations

Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses

Asier Sáez-Cirión;Martine Sinet;So Youn Shin;Alejandra Urrutia.
Journal of Immunology (2009)

241 Citations

Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy

Marc Dalod;Marion Dupuis;Jean-Christophe Deschemin;Didier Sicard.
Journal of Virology (1999)

216 Citations

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.

Véronique Juillard;Pascale Villefroy;Dominique Godfrin;Andrea Pavirani.
European Journal of Immunology (1995)

211 Citations

Preserved Central Memory and Activated Effector Memory CD4+ T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study

Simon J Potter;Christine Lacabaratz;Olivier Lambotte;Santiago Perez-Patrigeon.
Journal of Virology (2007)

209 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alain Venet

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 150

Christine Rouzioux

Christine Rouzioux

Necker-Enfants Malades Hospital

Publications: 108

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 70

Cécile Goujard

Cécile Goujard

University of Paris-Saclay

Publications: 58

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 57

Olivier Lambotte

Olivier Lambotte

University of Paris-Saclay

Publications: 55

Marcus Altfeld

Marcus Altfeld

Heinrich-Pette-Institute

Publications: 51

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 50

Mathias Lichterfeld

Mathias Lichterfeld

Brigham and Women's Hospital

Publications: 50

Laurence Meyer

Laurence Meyer

University of Paris-Saclay

Publications: 48

David Price

David Price

University of Aberdeen

Publications: 47

Xu G. Yu

Xu G. Yu

Ragon Institute of MGH, MIT and Harvard

Publications: 42

Michaela Müller-Trutwin

Michaela Müller-Trutwin

Université Paris Cité

Publications: 41

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 40

Brigitte Autran

Brigitte Autran

Grenoble Alpes University

Publications: 40

Eric S. Rosenberg

Eric S. Rosenberg

Harvard University

Publications: 39

Trending Scientists

Tridas Mukhopadhyay

Tridas Mukhopadhyay

Carnegie Mellon University

Joseph H. Schulman

Joseph H. Schulman

Alfred Mann Foundation

Mahbub Hassan

Mahbub Hassan

University of New South Wales

Satoshi Tsuneda

Satoshi Tsuneda

Waseda University

Ana L. Moore

Ana L. Moore

Arizona State University

T. E. Mitchell

T. E. Mitchell

Los Alamos National Laboratory

William F. Thompson

William F. Thompson

North Carolina State University

Inger Kappel Schmidt

Inger Kappel Schmidt

University of Copenhagen

Gordon E. Dickerson

Gordon E. Dickerson

United States Department of Agriculture

Markus Kaiser

Markus Kaiser

University of Duisburg-Essen

Constantine Londos

Constantine Londos

National Institutes of Health

Zhongtang Yu

Zhongtang Yu

The Ohio State University

Yafang Cheng

Yafang Cheng

Max Planck Institute for Chemistry

Christian Bogdan

Christian Bogdan

University of Erlangen-Nuremberg

Gideon Lack

Gideon Lack

King's College London

Robert C. Griggs

Robert C. Griggs

University of Rochester Medical Center

Something went wrong. Please try again later.